Centre Oscar Lambret at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Centre Oscar Lambret takes part in 4 sessions at ESMO 2026 in Madrid. Its program centres on metastatic hormone-sensitive prostate cancer and on how ESMO clinical practice guidelines shape standards of care. It presents updated survival for capivasertib plus abiraterone in PTEN-deficient disease and long-term survival with abiraterone plus prednisone when the cancer is metastatic at diagnosis.

OrganizationESMO 2026 Attendance
centreoscarlambret.fr
Cancer centre & hospital
Comprehensive cancer centre in Lille, France, part of the Unicancer network of French cancer centres.
Keynote
Fri Oct 23
12:38–12:48
Abstract
Fri Oct 23
14:34–14:39
Abstract
Sat Oct 24
10:15–10:25
Chair
Mon Oct 26
14:45–16:15

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Centre Oscar Lambret

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction